Mebeverine is a musculotropic antispasmodic drug without atropic side-effects whose major therapeutic role is in the treatment of irritable bowel syndrome. It is also indicated for treatment of gastrointestinal spasm secondary to organic disorder. It was first registered in 1965. It is manufactured and marketed as Colofac, Duspatal and Duspatalin by Solvay Pharmaceuticals.
Mebeverine is presented in the United Kingdom as a (135 mg) tablet. Other strengths: 100 mg tablet and 200 mg capsule.
Read more about Mebeverine: Mode of Action, Indications, Adverse Effects, Listed Side Effects